DDIT4L and melanoma: To test whether REDD2 also impairs the viability of human melanoma cell lines, we expressed DDIT4L in SK-MEL-28 and UACC-62 cells, which are devoid of endogenous REDD2 expression (see Supplementary Fig. S3C).